Insiders · NSRX

NSRX insider transactions

Nasus Pharma Ltd. (NSRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NSRX

• 34d
  Chief Executive Officer Teleman Dan Benjamin bought $20,305 worth of Ordinary Shares (6,550 units at $3.10), increasing direct ownership by 4% to 163,541 units (SEC Form 4)

  4 - Nasus Pharma Ltd (0002029039) (Issuer)
• 94d
  SEC Form 4 filed by Teleman Dan Benjamin

  4 - Nasus Pharma Ltd (0002029039) (Issuer)
• 116d
  SEC Form 4 filed by Teleman Dan Benjamin

  4 - Nasus Pharma Ltd (0002029039) (Issuer)
• 120d
  SEC Form 3 filed by new insider Rubin Eyal

  3 - Nasus Pharma Ltd (0002029039) (Issuer)
• 121d
  SEC Form 3 filed by new insider Teleman Dan Benjamin

  3 - Nasus Pharma Ltd (0002029039) (Issuer)
• 121d
  SEC Form 3 filed by new insider Silberman David

  3 - Nasus Pharma Ltd (0002029039) (Issuer)
• 121d
  SEC Form 3 filed by new insider Hershman Ronnie

  3 - Nasus Pharma Ltd (0002029039) (Issuer)
• 121d
  SEC Form 3 filed by new insider Shacham Sharon

  3 - Nasus Pharma Ltd (0002029039) (Issuer)
• 121d
  SEC Form 3 filed by new insider Gilboa Udi

  3 - Nasus Pharma Ltd (0002029039) (Issuer)
• 121d
  SEC Form 3 filed by new insider Megiddo Dalia

  3 - Nasus Pharma Ltd (0002029039) (Issuer)
• 121d
  SEC Form 3 filed by new insider Israel Isaac

  3 - Nasus Pharma Ltd (0002029039) (Issuer)